PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
September 12, 2025Annals of Clinical Psychiatry0 citations

Efficacy, Tolerability and Safety of Transcranial Magnetic Stimulation in Geriatric Depression: A State-of-the-Art Review

View Full Paper
ASAntoine SaderAmerican University of Beirut Medical CenterLDLéa DaouAmerican University of Beirut Medical CenterACAlfred ChabbouhAmerican University of Beirut

Key Points

  • Mixed results were found for standard repetitive TMS in treating geriatric depression, showing the need for tailored approaches.
  • Deep TMS demonstrated higher response and remission rates as it stimulates broader brain areas compared to standard techniques.
  • Theta burst stimulation offers shorter treatment durations with potential neuroplastic benefits, though effectiveness is target-dependent.
  • Transcranial magnetic stimulation was considered safe for older adults, with mild, transient side effects reported across modalities.

Abstract

Background With population ageing, addressing geriatric depression (GD) often underdiagnosed and inadequately treated is critical. This comprehensive review examines the efficacy, tolerability and safety of different transcranial magnetic stimulation (TMS) techniques for treating GD. Methods A literature review was conducted, focusing on different TMS modalities such as repetitive TMS (rTMS), theta burst stimulation (TBS), deep TMS (d-TMS), high frequency rTMS, and their application in older adults with depression. Results The efficacy of standard rTMS for GD showed mixed results, while non-conventional d-TMS demonstrated higher response and remission rates due to its ability to stimulate deeper and broader brain regions. TBS was noted for its shorter treatment durations and potential to enhance neuroplasticity, although effectiveness was highly dependent on the brain target. High-frequency rTMS and priming protocols suggested possible improvements in treatment outcomes. TMS was found to be safe and well-tolerated, with mostly mild and transient adverse effects in older adults. Conclusions Larger, placebo-controlled trials with standardized protocols are necessary to refine TMS techniques for GD, considering factors like brain atrophy, targeting precision, and treatment dosing. This review highlights TMS as a promising alternative to conventional treatments, warranting further research to optimize its clinical efficacy for GD.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Sader et al. (2025) studied this question.

synapsesocial.com/papers/68d44b2a31b076d99fa544f0https://doi.org/10.1177/10401237251350566
Ask AI
Helpful
Bookmark
Share
View Full Paper